HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
**Healthcare Services HealthPatient Outcomes Measure National Improve Audit Measure Improve Evaluate National Quality Improvement Evaluate Impact Patient Outcomes Benchmark Clinical Effectiveness Health**
**HQIP Trustees’ Report and Accounts** April 2024–March 2025
www.hqip.org.uk
1
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## **Trustees**
Dame Celia Ingham Clark (Chair) – _appointed 22 November 2024_ Dr Peter Bloomfield
Mark Hampton (Treasurer) Gillian Coverdale
Janice Gabriel Rosemary Jarvis – _resigned 23 May 2025_ Rachana Vyas – _appointed 30 July 2025_ Jane Dreaper – _appointed 30 July 2025_ Dr Jacqueline Andrews – _appointed 30 July 2025_
## **Chief Executive:**
Chris Gush
**Registered office:** 128 City Road, London EC1V 2NX
**Email:** communications@hqip.org.uk **Website:** www.hqip.org.uk **X:** @HQIP
**Company registration number:** 06498947 (England and Wales) **Charity registration number:** 1127049
**Auditors:** Buzzacott Audit LLP, 130 Wood Street, London EC2V 6DL **Bankers:** Lloyds Bank plc, 39 Threadneedle Street, London EC2R 8AU **Solicitors:** VWV Solicitors, Narrow Quay House, Narrow Quay, Bristol BS1 4QA
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## Contents
|Contents||
|---|---|
|**About HQIP**|**4**|
|**Chair and CEO statement**|**5**|
|**Our year in numbers**|**7**|
|**Strategic report**
**Strategic objectives**|**9**
**9**|
|**Achievements and performance**|**10**|
|**Future plans**|**15**|
|**Trustees’ report**|**16**|
|**Financial report**|**17**|
|**Independent auditor’s report**|**20**|
|**Statement of fnancial activities (including income and**
**expenditure account) for the year to 31 March 2025**|**24**|
|**Balance sheet 31 March 2025**|**25**|
|**Statement of cash fows for the year ended 31 March 2025**|**26**|
|**Notes to the accounts 2024-25**|**27**|
3
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## About HQIP
## _Measuring and improving our healthcare services_
The Healthcare Quality Improvement Partnership (HQIP) manages the UK’s largest suite of national clinical audits, outcome reviews and registries. Trusted by patients and clinicians alike, these programmes measure the quality of care delivered across hospitals and other service providers, providing publicly available data on a wide range of conditions from asthma to vascular health. They offer a clear view of what is working well and where improvement is needed most, and are an essential tool for improving patient care and outcomes.
More specifically, HQIP commissions and manages the National Clinical Audit and Patient Outcomes Programme (NCAPOP) on behalf of NHS England, the Welsh Government and others. This programme covers the National Clinical Audit Programme and Clinical Outcome Review Programmes which comprise of around 50 projects that collect and analyse healthcare data, in order to provide a national picture of care. We also host the National Joint Registry (NJR), which collects and analyses data relating to performance outcomes in joint replacement surgery, and holds millions of orthopaedic records.
Led by the Academy of Medical Royal Colleges (AoMRC) and the Royal College of Nursing (RCN), HQIP is an independent, not-for-profit organisation with a vision of _improved health outcomes for everyone through evidence-driven healthcare_ . Our real-world data helps to raise standards, reduce variations in care, and help every patient to receive the best possible treatment. In other words, our work – and its value – goes far beyond data collection and analysis. For example, the resources and services we offer support the NHS and other healthcare providers to address health inequalities and enhance productivity. We also pro-actively engage patients and carers to ensure that improvements are relevant and meaningful, and work with others across the sector to support them to do the same.
Critically, HQIP’s unique position as an independent organisation working with a wide range of stakeholders – from the clinical audit community, patients, and healthcare providers through to policy makers, charities and other national healthcare bodies – means that we can act as a ‘hub’ for evidence-informed healthcare improvement. We are able to foster partnerships and leverage data to share knowledge and current best practice, driving continuous improvement. This is exemplified by Clinical Audit Awareness Week, featuring the Clinical Audit Heroes Awards, an annual national campaign hosted by HQIP that promotes and celebrates the impact of clinical audit and quality improvement in healthcare.
**Further information about HQIP:** www.hqip.org.uk.
4
## _Thank you and welcome_
With the announcement on 13th March 2025 that “ _NHS England will be brought back into the Department of Health and Social Care (DHSC)”_ , we are approaching what will be, no doubt, a period of significant change for the healthcare sector in the UK. While we are poised to understand more about this major reform, one thing we are certain of is the resilience of the NHS and those involved in its delivery including, of course, patients.
What will be important going forward, is our collective response to the government’s aim to _“empower NHS staff to deliver better care for patients”_ . HQIP’s role in this response is clear. It is to provide evidence - focusing on outcome measures - to support targeted improvement that will save and improve patients’ lives. In other words, providing independent, clinicallyvalidated data. HQIP’s national clinical audits, outcome reviews and registries measure the quality of care of a wide spectrum of conditions, and are trusted by patients and clinicians alike. They provide a clear view of what is working well and where improvement is needed most, providing a foundation for change that will have maximum impact.
_“There is a moral obligation to use the data that is already available, for the benefit of patients”_ Phil, NHS patient
HQIP is delighted to welcome Dame Celia Ingham Clark as our new Chair. A former senior leader and deputy Medical Director at NHS England, Celia’s wealth of healthcare knowledge, together with HQIP’s expertise in evidence-informed improvement, provides a significant opportunity to maximise the impact that data has on patient outcomes.
We would like to take this opportunity to thank HQIP’s interim Chair, Peter Bloomfield, and outgoing Chair, Professor Dame Carrie MacEwen, for their many years of service and guidance, supporting improved patient outcomes.
In his Independent Investigation of the NHS in England (published in September 2024), Lord Darzi recognised the critical value of data-driven insights in - among other things - enhancing productivity and quality, engaging patients, and identifying variances and addressing inequities in care. Shifting care closer to home, preventing illness, and embracing technology were all important, if expected, themes. What is clear too, is his belief that these changes cannot be implemented without the bedrock of data. Indeed, numerous clinical audits are referenced in Lord Darzi’s report, underlining their value in tackling the challenges that he highlights.
Lord Darzi would like to see data play an even greater role in his _“road to reform”_ going forward, stating that _“the extraordinary richness of NHS datasets is largely untapped”_ . At HQIP, we welcome this. We can envisage getting to a position where we have neighbourhoodlevel electronic health records, from which data feeds seamlessly into national clinical audits and similar programmes, and is then analysed and sent back to the neighbourhood system to inform care. That, for us, is the holy grail of healthcare – a joined up service, based on evidence, that is designed to keep people healthy and reduce the chances of hospital admission. But, we mustn’t start from scratch. The data we already have must be the starting point for any major reform.
_“The extraordinary richness of NHS datasets is largely untapped”_ Lord Darzi
Rather than wait for the NHS 10 Year Health Plan to be implemented (published in the summer of 2025), we continue to strive daily to provide the data that will be required for its success. More importantly, we are generating the evidence that is required to save and improve the lives of all healthcare service users. Of course, we are not alone in this endeavour. We are indebted to a roll-call of clinical audit and quality improvement professionals, clinicians and other
healthcare providers, patients, healthcare planners, charities and other national healthcare bodies and stakeholders.
So, it is with great pleasure that we share HQIP’s 202425 annual report, which details just a small number of our achievements this year. Whether managing 49 national clinical audits and outcome review programmes (the largest of its kind in the UK) and the _“jewel in the crown of patient safety initiatives”_ * (the National Joint Registry), or running a national campaign to promote the value of clinical audit, we have been busy working on a myriad of projects to support improved care. We look forward to continuing this work, next year and beyond.
Best regards,
**Chris Gush Dame Celia Ingham Clark CEO Chair**
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## Our year in numbers
## **1 April 2024 to 31 March 2025**
**----- Start of picture text -----**
National Clinical Audit and Patient Outcomes Programme (NCAPOP)
Programmes and Reports Recommendations
49 audits managed 92 published 214
Peer-reviewed publications featuring
Infographics
39 72 HQIP-commissioned data
National Joint Registry (NJR) Tenders
Data analysed: 3 New NCAPOP contracts awarded
116,901 134,652 15
Hips Knees NCAPOP contract
Peer-reviewed 10 extensions
journal articles
on research
9,809 1,056 1,347
using NJR data
Shoulders Elbows Ankle replacements 5 HQIP supplier contracts awarded
National Clinical Audit Benchmarking
(NCAB) website*
8 5,118 53,762 748
Datasets Users Pageviews Downloads
added
**----- End of picture text -----**
7
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
**----- Start of picture text -----**
Patient & carer engagement
115 7 27 4
Service User Network (SUN) Focus groups Patient engagement Project
members (at 31 March 2025) in commissioning involvement
Clinical Audit Awareness HQIP online*
Week 2024
Clinical audit hero
52,816 223,225
145 award entries
Website users Website pageviews
Events
8
91,877 9,398
Downloads News/blog articles
New case studies,
5 articles and resources (including resources) pageviews
2,302
Social media
YouTube views
LinkedIn followers
(at 31 March 2025)
6,116
in} —*on
68,806 4,466
Impressions Engagement
Data access
X followers Applications
5,895 (at 31 March 2025) 130 received
X -
**----- End of picture text -----**
* We estimate that all website statistics provided are approximately 40% of the actual total, due to cookie permissions.
8
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## Strategic report
In shaping our objectives and planning our activities, the trustees have considered the Charity . Commission’s guidance on public benefit, including _Public benefit: running a charity (PB2)_ The trustees confirm that they have complied with the duty in section 17 of the Charities Act 2011 to have due regard to public benefit guidance published by the Charity Commission.
## **Strategic objectives**
In order to deliver our vision of improving health outcomes, a set of strategic objectives informs all our activities. As such, we committed to the following objectives for the year ended 31 March 2025:
**1.** Commission, manage, support and promote national and local programmes of quality improvement, using best management and procurement practice to ensure robust results and actionable recommendations. This includes the National Clinical Audit and Patient Outcomes Programme (NCAPOP), and the National Joint Registry on behalf of NHS England and other healthcare departments and bodies.
**2.** Ensure patients and carers remain at the heart of our work through continued, strategic involvement in all relevant processes and projects.
**3.** Support healthcare professionals to review and improve their practice by providing opportunities to share best practice, through education and training programmes, as part of promoting an integrated approach to quality improvement.
**4.** Inform and influence national healthcare policy by effectively communicating our work and that of our partners.
**5.** Encourage wide use of robust data for quality improvement of care, offering patient choice, promoting patient safety, supporting revalidation and service accreditation, commissioning, service redesign, and research.
**6.** Be an efficient, well run organisation which supports staff development and welfare.
## **These objectives were underpinned by the following key themes:**
**1.** Optimising Audit and Registry Programmes for Local and National Impact
**2.** Leadership in National Clinical Audits and Data Utilisation
**3.** Staff Empowerment and Organisational Excellence
**4.** Strategic Partnerships for Broader Impact
**5.** Technological Advancement for Agile and Charitable Operations
9
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## **Achievements and performance**
HQIP is proud to work with a multitude of others across healthcare to deliver our vision of _improved health outcomes for everyone through evidence-driven healthcare_ . By running the largest suite of national clinical audits, outcome reviews and registries in the UK, we make highquality data on a wide range of clinical disciplines available to all; an essential tool for supporting efficiencies, reducing inequalities and, importantly, improving patient care and outcomes. Managed independently, and trusted by patients
_“We collect more data on quality of care than any other country. Let’s use it, let’s get it out there,”_ Dr Penny Dash, NHS England Chair
and clinicians alike, these programmes measure the quality of care, providing a clear view of what is working well and where improvement is needed most.
to vascular health. This year, HQIP managed 49 audits and outcome reviews, publishing 92 reports and 39 infographics, featuring 214 recommendations for improvement.
## **National Clinical Audit and Patient Outcomes Programme (NCAPOP)**
Commissioned by HQIP on behalf of NHS England and other national healthcare bodies, the NCAPOP supports the collection and analysis of critical data on patient outcomes across a range of clinical disciplines, from asthma
Further information: Reports and infographics published by HQIP.
## **Spotlight:** Impact of clinical audit in neonatal care
In just four years, the use of Deferred Cord Clamping (DCC) for preterm babies rose from less than 29% in 2020 to almost 70% in 2023. This simple intervention is estimated to reduce neonatal mortality by around onethird and, as such, the improvement in adoption rate was significant in saving the lives of newborn babies in recent years.
_“The world stopped and nothing else mattered”_ parents of baby Allegra, born at 31 weeks’ gestation
The National Neonatal Audit Programme (NNAP), commissioned by HQIP, played a vital role in this transformation in neonatal care. By working with NHS England, the British Association of Perinatal Medicine (BAPM), Perinatal Clinical Networks (PCNs) and others, the NNAP helped to shine a light on variation, by
identifying service providers with lower-than-average use of DCC and supporting them to change their practice.
Progress has been rapid. The percentage of eligible babies born at less than 34 weeks’ gestation receiving DCC has gone from less than 29% in 2020 to 68.3% in 2023 – and is expected to exceed 70% when 2024 data is released. Of course, behind these statistics are many, many families whose lives have been transformed. Nick and Gemma, parents of baby Allegra, born at 31 weeks’ gestation, described their experience simply with: _“The world stopped and nothing else mattered”_ .
The NNAP demonstrates the power of clinical audit to deliver real-world impact. With high-quality data, clear benchmarking and collaborative action, neonatal services were able to achieve a measurable, life-saving improvement for some of the most vulnerable patients when they needed it most.
Further information: Article on the impact of the NNAP.
10
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## **National Joint Registry**
The National Joint Registry (NJR) ~~ee~~ , hosted by HQIP, is the largest orthopaedic registry of its kind in the world. It now holds data on more than 4.5 million surgical procedures, growing year-on-year since its launch in 2002, offering unrivalled insight into the safety and effectiveness of joint replacement surgery. In the past year alone, the NJR has analysed over 250,000 joint replacements. This comprehensive coverage across all major joint types allows the NJR to track performance at implant, surgeon and hospital level, identifying variation and driving improvements in patient care.
_safety initiatives”_ , and by Baroness Cumberlege in the Independent Medicines and Medical Devices Safety Review as a _‘global exemplar of an implantable medical device registry’_ , the NJR continues to be both a safeguard and a springboard, protecting patients today and shaping the orthopaedic care of tomorrow.
Further information: The National Joint Registry - Working for patients, committed to excellence.
_“The jewel in the crown of patient safety initiatives”_ Professor Sir Stephen Powis, then National Medical Director of NHS England
The registry’s latest Annual Report shows a continued reduction in joint revision surgery; evidence that implants are lasting longer, and outcomes for patients are improving year on year. The NJR’s interactive reporting platform now makes this information even more accessible, providing clinicians and hospital staff with real-time data, as well as statistical analysis to support evidence-based best practice. Patients can look up their proposed consultant surgeon and hospital on the ~~a~~ NJR’s Surgeon and Hospital Profle, where the last three years of activity is available. If considering a hip or knee replacement, they can use the NJR’s Patient Decision Support Tool.
Beyond monitoring outcomes, the NJR actively enables innovation through research. Fellowship programmes supported by the NJR and academic partners are tackling key questions, ranging from the impact of mental health on knee replacement outcomes through to the longevity of elbow and shoulder implants. Described by Professor Sir Stephen Powis, then National Medical Director of NHS England, as _“the jewel in the crown of patient_
_NJR Presence at British Orthopaedic Association (BOA) Congress, Liverpool 2025_
11
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## **Wider benefits of HQIP data**
HQIP-commissioned audits and outcome reviews collect, analyse and report data to help improve the quality and outcomes of healthcare – but we also understand that there is much added value in utilising this data for public benefit in other ways, such as research. To facilitate this, we operate a Data Access Request Group (DARG), processing 130 requests for data from April 2024-March 2025.
_“Healthcare data is viewed as a gift by those considering access to it”_ public member of HQIP’s DARG
This group plays a vital role in ensuring that healthcare data is used to improve care, shape services and support high quality research. By guiding access requests through a clear and transparent process, DARG enables data to be shared responsibly and for the greatest possible value to patients and the general public, all while maintaining patient trust.
## **Spotlight:** The importance of data sharing from a patient perspective
At the heart of HQIP’s DARG process are members of the general public, who bring a unique and essential perspective. Their involvement ensures that decisions always reflect what matters most to patients and families, a responsibility that is not taken lightly. Or, as one public member puts it: _“Healthcare data is viewed as a gift by those considering access to it”._
For patient representatives, contributing to DARG is both meaningful and rewarding. Their commitment demonstrates the importance of using data responsibly to create positive change. Phil, a DARG representative and long-time NHS patient, underlines this ethos: _“I believe that data provides a sound rationale for why we offer care in the way we do, but I joined DARG to make sure that it is used primarily for the benefit of patients”._
Further information: Article on ‘My data, my health’.
## **Effective patient engagement**
In order to make improvement meaningful and relevant to patients, it is imperative that we engage with them in everything we do. From supporting the development of programme specifications to co-producing resources (and a wide range of other activities in between), Patient and Public Involvement (PPI) is central to the success of HQIP’s work.
Our patient engagement activity this year included involvement in conception through to delivery of the commissioning of programmes in the National Clinical Audit and Patient Outcomes Programme (NCAPOP), as well as HQIP’s wider work to support improvement in healthcare, including:
- Input into the development of programme specifications, both new and extensions, eg Medical and Surgical Clinical Outcome Review Programme
- Focus groups to provide feedback on the programmes, eg the National Audit of Cardiovascular Disease Prevention in Primary Care (CVDPrevent)
- Creation of an obesity-focused user panel to feed into the National Obesity Audit and the wider NHS England prevention programme
- Supporting the management of HQIP’s programmes through attendance at moderation and contract review meetings, eg for the National Audit of Dementia
- Development of a case study on Embedding patient voice in procurement
12
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
- Recruitment of patient representatives for HQIP’s Data Access Request Group (DARG)
- Co-production of HQIP’s first _Working in Partnership with Patient Advocates_ Involvement Policy.
HQIP’s Service User Network (SUN) is a group of patients and carers with lived experience of healthcare services, and
they are central to the success of HQIP’s PPI activity. As of 31 March 2025, we had 115 actively engaged people working with us to improve the quality of healthcare services – and that number is still growing!
Further information: Patient engagement at HQIP.
## **Spotlight:** How patient voice supports improvement in respiratory care
The HQIP-commissioned National Respiratory Audit Programme (NRAP) works with patients on an on-going basis to identify improvements that they themselves have prioritised – which, in turn, leads to meaningful changes to care. One recent example was the co-design of separate resources for adults and children, to support effective discharge planning – something which has been demonstrated to have a direct impact on better health outcomes for patients with asthma and COPD.
_“Having a little time at discharge to make sure everything you’re expecting has happened can break the cycle of breathing problems before they get worse again”_ Heather, patient
care are important, and includes prompt questions that patients can ask healthcare professionals.
- For CYP hospital teams: _Checklist for discharge from hospital after an asthma attack_ . A simple document for healthcare workers to complete with CYP and their families when they are being discharged.
With this project, NRAP demonstrates how thoughtful, patient-informed clinical audit that engages patients leads to improved care outcomes – because only they truly know the impact that their illness has on them. A sentiment which is summed up perfectly by Heather, a respiratory patient: _“As patients, we rely on this audit process to help make sure our conditions are managed consistently”_ .
Further information: Article on ‘A powerful partnership improving asthma and COPD care’
Developed by working with patient panels, alongside Asthma and Lung UK and clinicians, these innovative resources were designed with – and for – patients. They empower patients to understand the care that they should be receiving during treatment, and in particular at discharge:
- For children and young people (CYP) and their families/caregivers: _What should you expect to receive when you’re discharged from hospital after an asthma attack?_ Explains why certain aspects of
13
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## **Addressing health inequities**
Clinical audit plays a crucial role in addressing health inequities. It enables a deeper understanding of the challenges, and informs the development of tailored
solutions that can more effectively meet the needs of diverse populations. With the largest national clinical audit programme in the UK, HQIP’s data offers invaluable insights that can lead to improved care and outcomes for the most vulnerable in our society.
## **Spotlight:** Audit data helps to close the gap in maternity care
A landmark retrospective study demonstrated how national clinical audit data can lead to better outcomes in maternity care, highlighting the critical importance of these programmes. Published in February 2025 in the Journal of Public Health, the research identified 23 ‘red flag’ Trusts – almost one in five of those included – that consistently fell in higher risk categories. Critically, it also found that seven Trusts reported higher-than-average deaths across all seven years, offering the opportunity to not only improve care, but also save lives.
To develop these life-saving insights, the study compared HQIP-commissioned MBRRACE-UK reports from 2015 to 2021 with perinatal mortality rates across 124 hospital Trusts in England between 2013 and 2019.
The resultant evidence enables targeted scrutiny and accountability, and supports maternity services to understand where change will have the greatest impact – and deliver improvements accordingly.
By uncovering patterns and guiding tailored solutions, we can see how clinical audit has a direct impact on healthcare inequities, ensuring safer care for mothers and babies alike. HQIP is proud to be a part of this work, ensuring that data is not just collected but is translated into meaningful action that saves and improves lives.
Further information: New study uses - HQIP commissioned data to identify ‘ ’ recurring red fags in maternity.
## **Clinical Audit Awareness Week**
Clinical Audit Awareness Week, a national campaign hosted by HQIP to promote and celebrate the benefits of clinical audit, took place from 24-28 June 2024. Run in collaboration with the clinical audit network N-QI-CAN and including the Clinical Audit Heroes Awards, this annual event was an enormous success, bringing together the whole community and featuring:
- A live online conversation with Stella Vig, National Medical Director for Secondary Care and Quality, NHS England
the Patient Safety, NHS Horizons, Making Data Count and Healthcare Inequalities teams at NHS England
- A case study event from HQIP’s flagship programme, the National Cancer Audit Collaborating Centre (NATCAN), on their collaborative approach to clinical audit
- New resources on using data to address healthcare inequalities and effective public engagement, featuring members of HQIP’s Service User Network (SUN), as well as daily signposting to resources to support quality improvement.
- A joint webinar with the NHS England IMPACT team ~~a~~ on quality improvement
- Daily Lunch & Learn events, featuring the award winners and N-QI-CAN, as well as a range of speakers including
14
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## **Future plans**
## **Planned activity for 2025-26**
The operational plan for 2025-26 was based on three strategic objectives:
- Continuing flagship activities
- Expanding support services: procurement, patient engagement and quality improvement
- Establishing the Association for Clinical Audit and Registries.
To ensure the success of the strategic objectives, the following cross-cutting themes will be integrated across all activities:
## **Risk management**
The Board of Trustees maintains a comprehensive Risk Register which is reviewed and discussed at every Board Meeting. Risks fall into five categories:
- Governance
- Operational
- Financial
- Environmental/external
- Compliance (laws and regulations).
The probability and impact of each risk is calculated and the charity’s mitigation strategy for each is considered.
- Collaboration and partnerships
- Sustainability
- Thought leadership and policy influence
- Patient and carer involvement
- Professional development and support
- Organisational excellence and staff welfare
- Data accessibility and utilisation.
Some of the key activities planned for 2025-26 are:
- Contribute, influence and align with the NHS England 10-year plan and the new NHS England strategy for clinical audit, registries and databases
- Develop the new NJR 5-year strategic plan
The principal risks are considered to be:
## **Risk 1: Dependency on one substantive contract**
**Mitigation:** Continued efforts to diversify income and reduce dependency led by Associate Director for Quality Improvement, supported by New Business Development Executive. Partnerships and procurement frameworks are both being actively pursued.
## **Risk 2: Disbandment of NHS England and transition to Department of Health and Social Care**
**Mitigation:** Policy engagement at multiple levels, strategic alignment, development of the Association for Clinical Audit and Registries as a future platform.
- Undertake stakeholder relationship-building activities to extend the reach of NCAPOP and NJR outputs, including structured engagement with national networks, royal colleges, and improvement collaboratives
- Redevelop the HQIP website to ensure data and reports are accessible to a wider quality improvement audience
- Build strategic relationships to position HQIP as the national hub for clinical audit and registries.
15
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## Trustees’ report
The trustees, who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 March 2025.
The trustees have adopted the provisions of the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (The FRS 102 Charities SORP including Update Bulletin 2). In accordance with paragraph 15.6 of The FRS 102 Charities SORP, a combined trustees’ report and directors’ report have been presented. This combined annual report contains the directors’ report as required by company law.
## **Statement of Trustees’ responsibilities**
The trustees (who are the directors of the charitable company for the purposes of company law) are responsible for preparing the trustees’ report and the financial statements in accordance with applicable law and regulations.
Company law requires the trustees to prepare financial statements for each financial year. Under that law, the trustees have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the income and expenditure of the charitable company for that period.
In preparing these financial statements, the trustees are required to:
- observe the methods and principles in the Charities SORP;
- select suitable accounting policies and then apply them consistently;
- make judgements and estimates that are reasonable and prudent;
- state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in business.
The trustees are responsible for maintaining proper accounting records which disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
In so far as the trustees are aware:
- There is no relevant audit information of which the charitable company’s auditor is unaware; and
- The trustees have taken all the steps that they ought to make themselves aware of any relevant audit information and to establish that the auditor is aware of that information.
The Trustees’ Annual Report is approved by the trustees of the Charity. The Strategic Report, which forms part of the Annual Report, is approved by the trustees in their capacity as directors in company law of the Charity.
16
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## **Financial report**
## **Results for the year**
## **Fig 1: Where our funding comes from**
## **Fig 2: How we spend our money**
17
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
During the year ended 31 March 2025, HQIP received income totalling £21,976,055 (2024: £21,571,509) of which £19,568,028 (2024: £19,167,213) was for restricted purposes, and £2,408,027 (2024: £2,404,296) was for the general purposes of the charity including management support fees of £1,999,456 (2024: £1,999,455).
Income included £8,947,925 (2024: £9,541,966) to finance national clinical audits. In addition, HQIP collected subscriptions of £2,000,000 (2024: £2,010,000) from NHS Trusts on behalf of NHS England to support national audits. The Scottish Government contributed £197,440 (2024: £195,970) to NCAPOP.
In 2024-25, income for the Clinical Outcome Review Programmes totalling £3,414,503 (2024: £2,833,541) was collected from all UK Administrations. This included funding for the National Child Mortality Database.
In 2024-25, the National Joint Registry (NJR) collected subscriptions totalling £3,545,502 (2024: £3,311,343). Other income of £897,555 (2024: £877,336) included supplier contributions, and data access fees. NJR funds are used solely to fund the work of the Registry.
Grants totalling £20,000 (2024: £20,000) were received from the Health Foundation and £Nil (2024: £10,668) from Health Data Research UK. £45,000 (2024: £Nil) was received from NHS England for Independent Sector scoping work and £Nil (2024: £72,000) for a maternity project.
## **Expenditure**
In 2024-25, HQIP commissioned and managed national clinical audit contracts with a total value of £9,767,937 (2024: £9,450,275).
Expenditure on the Clinical Outcome Review Programmes was £3,760,213 (2024: £3,381,983).
Expenditure on the management and development of the National Joint Registry was £3,948,961 (2024: £3,817,187).
Expenditure on National Clinical Audit Benchmarking was £11,966 (2024: £6,870). Expenditure on other Quality Improvement and Development activities was £22,985 (2024: £21,796).
Other direct charitable expenditure, including support costs, totalled £2,520,797 (2024: £2,401,820).
## **Financial position**
The balance sheet at 31 March 2025 shows total funds of £20,854,119 (2024: £18,910,923), including restricted funds totalling £17,067,866 (2024: £15,584,335) and unrestricted funds comprising general funds of £3,322,798 (2024: £2,859,416), tangible and intangible fixed assets of £17,016 (2024: £20,733) and designated funds of £446,439 (2024: £446,439).
At 31st March 2025, the charity retained free reserves of £3,322,798 (2024: £2,859,416).
## **Reserves policy**
The trustees have examined the requirement for free reserves, i.e. those unrestricted funds not invested in tangible or intangible fixed assets, designated for specific purposes or otherwise committed. The current policy is that the level of free reserves should be equivalent to six to twelve months’ operating commitments (forecast at £1,615,990 to £3,231,979 in 2025-26). The actual free reserves of £3,322,798 at March 2025 were slightly above this range but this is considered reasonable given the uncertainty around the transition from NHS England to the Department of Health and Social Care.
There are, in addition, designated funds of £446,439 (see Note 18). The designated Stability fund is available to support business development activities, additional IT infrastructure costs and continuity of workstreams over the next 5 years. Trustees keep this position under regular review.
18
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## **Structure, governance and management**
HQIP is a company limited by guarantee and incorporated on 11 February 2008. It was registered as a charity on 4 December 2008. The governing document is the Memorandum and Articles of Association. HQIP was founded by a consortium of three organisations: the Academy of Medical Royal Colleges, the Royal College of Nursing, and National Voices.
The Academy of Medical Royal Colleges and the Royal College of Nursing remain as member organisations. Each member organisation appoints representatives to act as directors and these individuals, together with the treasurer and any other independently appointed individuals, form the trustees of the organisation and the Board of Directors. A process for induction of new trustees is in place and ongoing training for trustees is available as required.
Remuneration for all staff, including key management personnel, is set by reference to periodic external salary benchmarking.
Trustees’ Report and Strategic Report approved by the trustees of Healthcare Quality Improvement Partnership company registration number 06498947 (England and Wales) and signed on their behalf by:
Trustee Dame Celia Ingham Clark, Chair. Approved on: 27 November 2025
The trustees handle matters of strategic planning and policy, including sign-off of the charity’s strategic and operational plans. The Chief Executive has delegated responsibility for managing the charity and handling operational matters of policy and delivery.
19
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## Independent auditor’s report to the members of Healthcare Quality Improvement Partnership
## **Opinion**
We have audited the financial statements of Healthcare Quality Improvement Partnership (the ‘charitable company’) for the year ended 31 March 2025 which comprise the statement of financial activities, the balance sheet, and statement of cash flows, the principal accounting policies and the notes to the financial statements. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ (United Kingdom Generally Accepted Accounting Practice).
In our opinion, the financial statements:
- give a true and fair view of the state of the charitable company’s affairs as at 31 March 2025 and of its income and expenditure for the year then ended;
- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
- have been prepared in accordance with the requirements of the Companies Act 2006.
## **Basis for opinion**
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit
of the financial statements in the UK, including the FRC’s Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
## **Conclusions relating to going concern**
In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.
## **Other information**
The other information comprises the information included in the annual report, including the strategic report and trustees’ report, other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not
20
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.
Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements, or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
## **Opinions on other matters prescribed by the Companies Act 2006**
In our opinion, based on the work undertaken in the course
following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of trustees’ remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.
## **Responsibilities of trustees**
As explained more fully in the trustees’ responsibilities statement, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
of the audit:
- the information given in the trustees’ report, which is also the directors’ report for the purposes of company law and includes the strategic report, for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the trustees’ report, which is also the directors’ report for the purposes of company law and includes the strategic report, has been prepared in accordance with applicable legal requirements.
## **Matters on which we are required to report by exception**
In the light of the knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the trustees’ report including the strategic report. We have nothing to report in respect of the
In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.
## **Auditor’s responsibilities for the audit of the financial statements**
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or
21
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of noncompliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:
- the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise noncompliance with applicable laws and regulations;
- we identified the laws and regulations applicable to the company through discussions with management, and from our commercial knowledge and experience of the sector;
- the identified laws and regulations were communicated within the audit team regularly and the team remained alert to instances of non-compliance throughout the audit;
- we focused on specific laws and regulations which we considered may have a direct material effect on the accounts or the activities of the company. These included but were not limited to the Companies Act 2006, Charities Act 2011 and the Charities SORP; and
- we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management, inspecting legal correspondence and reviewing trustee meeting minutes.
We assessed the susceptibility of the charitable company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:
- making enquiries of management and those charged with governance as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and
- considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.
To address the risk of fraud through management bias and override of controls, we:
- performed analytical procedures to identify any unusual or unexpected relationships;
- tested journal entries to identify unusual transactions;
- tested the authorisation of expenditure as part of our substantive testing thereon;
- assessed whether judgements and assumptions made in determining the accounting estimates set out in the accounting policies were indicative of potential bias; and
- used data analytics to identify any significant or unusual transactions and identify the rationale for them.
In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:
- agreeing financial statement disclosures to underlying supporting documentation;
- reading the minutes of trustee meetings; and
- enquiring of management and those charged with governance as to actual and potential litigation and claims. There are inherent limitations in our audit procedures described above.
22
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify noncompliance with laws and regulations to enquiry of the trustees and other management and the inspection of regulatory and legal correspondence, if any.
Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.
Alison Pyle (Senior Statutory Auditor)
For and on behalf of Buzzacott Audit LLP, Statutory Auditor 130 Wood Street London EC2V 6DL
Date: 28 November 2025
A further description of our responsibilities is available on the Financial Reporting Council’s website at www.frc.org.uk/ auditorsresponsibilities. This description forms part of our auditor’s report.
## **Use of our report**
This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.
23
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## Statement of financial activities (including income and expenditure account) for the year to 31 March 2025
**----- Start of picture text -----**
Unrestricted Restricted Total Total
Funds Funds 2025 2024
Note £ £ £ £
Income
Income from 2 112,697 520,103 632,800 378,740
Investments
Charitable Activities
Management, 3 2,282,351 19,047,925 21,330,276 21,129,809
development and
promotion of
Clinical Audit
Other income 4 12,979 - 12,979 62,960
Total Income 2,408,027 19,568,028 21,976,055 21,571,509
Expenditure
Charitable activities
Management, 5 1,950,544 18,082,315 20,032,859 19,079,931
development and
promotion of
Clinical Audit
Total Expenditure 1,950,544 18,082,315 20,032,859 19,079,931
Net Income 7 457,483 1,485,713 1,943,196 2,491,578
Transfers between funds 16 2,182 (2,182) - -
Net movement in funds 459,665 1,483,531 1,943,196 2,491,578
Balances brought 3,326,588 15,584,335 18,910,923 16,419,345
forward at 1 April 2024
Balances carried 3,786,253 17,067,866 20,854,119 18,910,923
forward at 31 March 2025
**----- End of picture text -----**
All gains and losses arising in the period have been included in the statement of financial activities and relate to continuing operations.
24
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## Balance sheet 31 March 2025
|~~ee~~
~~ee~~|~~ee~~
~~ee~~|**2025**
~~ee~~|**2025**
~~ee~~|**2024**
~~ee~~|**2024**|
|---|---|---|---|---|---|
|~~ee~~
~~ee~~|Notes
~~ee~~
~~ee~~|**£**
~~ee~~|**£**
~~ee~~|£
~~ee~~|£|
|**Fixed assets**
~~ee~~
~~ee~~
~~ee~~|~~ee ~~
~~ee~~
~~ee~~|~~ee~~|~~ee~~|~~ee~~||
|Intangible fixed assets
~~ee ~~
~~ee~~
~~ee~~|**11**
~~ee~~
~~ee~~
~~ee ee~~|~~ee~~|**-**
~~ee~~|~~ee~~|-|
|Tangible fixed assets
~~ee ~~
~~ee~~
~~ee~~|**12**
~~ee~~
~~ee ee~~
~~ee es~~|~~ee~~
~~es~~|**17,016**
~~ee~~|~~ee~~|20,733|
|~~ee ~~
~~ee~~
~~ee~~|~~ee ee~~
~~ee es~~
~~ee~~|~~ee~~
~~es~~|**17,016**
~~ee~~|~~ee~~|20,733|
|**Current assets**
~~ee~~
~~ee~~|~~ee es~~
~~ee~~|~~es~~
~~ee~~|~~ee~~|||
|Debtors due within
one year
~~ee~~
~~ee~~|**13**
~~ee~~
~~ee~~|**478,358**
~~ee~~
~~ee~~
~~ee~~|~~ee~~
~~ee~~
~~ee~~|882,391
~~ee~~|~~ee~~|
|Current asset
investments
~~ee~~
~~ee~~
~~ee~~|**14**
~~ee~~
~~ee~~|**5,023,564**
~~ee~~
~~ee ~~
~~ee~~
~~ee~~
~~ee~~|~~ee~~
~~ee~~
~~ee~~
~~ee~~
~~ee~~|4,655,267
~~ee~~
~~ee~~
~~eee~~|~~ee~~
~~ee~~
~~eee~~|
|Cash at bank and
in hand
~~ee~~
~~a~~
~~ee~~|~~ee~~
~~a~~|**20,310,881**
~~ee~~
~~ee ~~
~~a~~
~~ee~~|~~ee~~
~~ee~~
~~a~~
~~ee~~|18,369,291
~~ee~~
~~a~~
~~eee~~|~~ee~~
~~a~~
~~eee~~|
|~~a~~
~~ee~~|~~a~~|**25,812,803**
~~a~~
~~ee~~|~~a~~
~~ee~~|23,906,949
~~a~~
~~eee~~|~~a~~
~~eee~~|
|**Creditors:**amounts
falling due within
one year
~~ee~~
~~ee~~|**15**
~~ee ee~~|**4,975,700**
~~ee ~~
~~ee~~|~~ee ~~
~~ee~~|5,016,759
~~eee~~
~~ee~~|~~eee~~|
|**Net current assets**
~~ee~~
~~ee~~|~~ee ee~~
~~es~~|~~ee~~|**20,837,103**
~~ee~~|~~ee~~|18,890,190|
|**Total net assets**
~~ee~~
~~ee~~
~~ee~~|~~ee ee~~
~~es~~
~~ee ee~~|~~ee~~
~~ee~~|**20,854,119**
~~ee~~
~~ee~~|~~ee~~
~~ee~~|18,910,923|
|~~ee~~
~~ee~~
~~ee~~|~~es~~
~~ee ee~~
~~se~~|~~ee~~
~~se~~|~~ee~~
~~se~~|~~ee~~
~~se~~|~~se~~|
|**Funds and reserves**
~~ee~~
~~ee~~
~~ee~~|~~ee ee~~
~~se~~
~~es~~|~~ee~~
~~se~~|~~ee~~
~~se~~|~~ee~~
~~se~~|~~se~~|
|Restricted funds
~~ee~~
~~ee~~
~~ee~~|**16**
~~se~~
~~es~~
~~ee~~|~~se~~|**17,067,866**
~~se~~|~~se~~|15,584,335
~~se~~|
|Unrestricted funds
~~ee~~
~~ee~~
~~ee~~|~~es~~
~~ee~~
~~ee~~|||||
|General fund
~~ee ~~
~~ee~~
~~ee~~|~~ee~~
~~ee~~|**3,322,798**
~~ee~~|~~ee~~|2,859,416
~~ee~~|~~ee~~|
|Tangible fixed
assets fund
~~ee ~~
~~ee~~
~~ee~~
~~es~~|**17**
~~ee~~
~~ee~~
~~es~~
|**17,016**
~~ee~~
~~ee~~
|~~ee~~
~~ee~~
|20,733
~~ee~~
~~ee~~|~~ee~~
~~ee~~|
|Designated funds
~~ee~~
~~ee~~
~~es~~
~~ee~~|**18**
~~ee~~
~~es~~
~~ee~~|**446,439**
~~ee~~
~~ee~~
~~ee~~|~~ee~~
~~ee~~
~~ee~~|446,439
~~ee~~
~~ee~~
~~ee~~|~~ee~~
~~ee~~|
|~~ee~~
~~es~~
~~ee~~|~~es~~
~~ee~~|~~ee ~~
~~ee~~|**3,786,253**
~~ee~~
~~ee~~|~~ee~~
~~ee~~|3,326,588
~~ee~~|
|~~es ~~
~~ee~~|~~es~~
~~ee~~
~~es~~|~~ee~~
~~es~~|**20,854,119**
~~ee~~|~~ee~~|18,910,923|
Trustee Dame Celia Ingham Clark, Chair. Approved on: 27 November 2025
25
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## Statement of cash flows for the year ended 31 March 2025
**----- Start of picture text -----**
2025 2024
£ £
Cashflow from operating activities
Net cash provided by operating activities 1,685,899 1,263,280
Cashflows from investing activities
Investment income and interest received 632,800 378,740
(Increase)/Decrease in current asset investments (368,297) (4,655,267)
Proceeds from sale of tangible fixed assets 438 -
Payments to acquire tangible fixed assets (9,250) (12,866)
255,691 (4,289,393)
Net (decrease)/increase in cash and cash equivalents 1,941,590 (3,026,113)
Cash and cash equivalents at the beginning of the year 18,369,291 21,395,404
Cash and cash equivalents at end of year 20,310,881 18,369,291
Reconciliation of net income to net cash flow from operating activities
Net income / (expenditure) including endowments 1,943,196 2,491,578
Adjustments for:
Depreciation charge 12,525 11,259
4 -
Loss on disposal of fixed assets
Interest receivable (632,800) (378,740)
(Increase)/Decrease in debtors 404,033 (556,139)
(Decrease)/Increase in creditors (41,059) (304,678)
Net cash inflow from operating activities 1,685,899 1,263,280
**----- End of picture text -----**
## **Analysis of changes in net funds**
**----- Start of picture text -----**
At 1 April 2024 Cash-flows Other non cash changes At 31 March 2025
£ £ £ £
Cash and cash equivalents 18,369,291 1,941,590 - 20,310,881
Current asset investments 4,655,267 - 368,297 5,023,564
Total net funds 23,024,558 1,941,590 368,297 25,334,445
**----- End of picture text -----**
26
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## Notes to the accounts 2024-25
## **1. Accounting policies**
## **a) Basis of accounting**
These financial statements are prepared on a going concern basis, under the historical cost convention.
The financial statements have been prepared in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). The Charitable Company is a public benefit entity for the purposes of FRS 102 and therefore the Charity also prepared its financial statements in accordance with the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (The FRS 102 Charities SORP including Update Bulletin 2), the Companies Act 2006 under the provision of the Large and Mediumsized Companies and Groups (Accounts and Reports) Regulations 2008 (SI 2008/410) and the Charities Act 2011.
The financial statements are prepared in sterling, which is the functional currency of the company.
Monetary amounts in these financial statements are rounded to the nearest pound.
## **b) Going concern**
The trustees have assessed whether the use of the going concern basis is appropriate and have considered possible events or conditions that might cast significant doubt on the ability of the charity to continue as a going concern. The trustees have made this assessment for a period of at least one year from the date of approval of the financial statements. In particular the trustees have considered the charity’s forecasts and projections and have taken account of pressures on grant income. After making enquiries the trustees have concluded that there is a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. The charity therefore continues to adopt the going concern basis in preparing its financial statements.
## **c) Income**
Income is recognised net of VAT in the period in which the charity is entitled to receipt and the amount can be measured with reasonable certainty. Income is deferred only when the charity has to fulfil conditions before becoming entitled to it or where the donor or funder has specified that the income is to be expended in a future accounting period. If the funder does not specify that the income must be expended in a future accounting period, the income is recognised when the other conditions of entitlement are satisfied. Income is only recognised for amounts that are probable at the date of preparation of the accounts. Any further amounts received after this date are recognised in subsequent periods.
Funding from government and other agencies has been included as income from charitable activities where these amount to either a contract for services or the charity has acted as agents. However where the money is given in response to an appeal or with greater freedom of use, for example monies for core funding, then this has been treated as a donation.
Investment income consists of bank interest receivable and is recognised when receivable and the amount can be measured reliably.
## **d) Expenditure and the basis of apportioning costs**
Expenditure is included in the Statement of Financial Activities when incurred and excludes attributable VAT where it can be recovered.
Expenditure comprises the following:
i) The costs of activities in furtherance of the charity’s objects comprise expenditure on the charity’s primary charitable purposes as described in the trustees’ report.
27
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
Such costs include:
- National Clinical Audit and Patient Outcomes Programme: amounts expended on the commissioning of national clinical audits
- Clinical Outcome Review Programmes: commissioning and managing enquiries and reviews
- National Joint Registry: expenditure relating to the management and development of the Registry
- Quality improvement and development activities: expenditure relating to the promotion and advancement of clinical audit as a means of improving the provision of healthcare.
ii) Support costs represent indirect charitable expenditure. In order to carry out the primary purposes of the charity it is necessary to provide support in the form of personnel development, financial procedures, provision of office services and equipment and a suitable working environment. Such costs are allocated across the activities of the charity based on estimates of staff time, activity, headcount or a proportion of income.
## **e) Cash and cash equivalents**
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts.
## **f) Current asset investments**
Current asset investments consists of short-term liquid investments with original maturities of between three and twelve months.
## **g) Fund accounting**
Restricted funds comprise monies whose use is restricted to a specific purpose, or is subject to donor imposed conditions.
The fixed assets fund comprises the net book value of the charity’s fixed assets, the existence of which is fundamental to the charity being able to perform its charitable work and thereby achieve its charitable objectives. The value represented by such assets should not be regarded, therefore, as realisable.
General unrestricted funds represent those monies which are freely available for application towards achieving any charitable purpose that falls within the charity’s charitable objects.
## **h) Tangible fixed assets**
All assets costing more than £500 and with an expected useful life exceeding one year are capitalised. Depreciation is provided at the following annual rates in order to write each asset off over its estimated useful life:
- Fixtures, fittings and equipment: 33% per annum based on costs
## **i) Intangible fixed assets**
Intangible fixed assets include the development costs of the website and are stated at cost less accumulated amortisation and accumulated impairment losses. Amortisation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following basis:
- Website development costs: 33% per annum based on costs
## **j) Pension contributions**
The cost of the defined contribution scheme is equal to the contributions payable to the scheme for the accounting period.
## **k) Employee benefits**
The costs of short-term employee benefits are recognised as a liability and an expense.
Designated funds comprise monies set aside out of unrestricted general funds for specific future purposes or projects.
28
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## **l) Redundancy and termination payments**
Redundancy and termination costs are recognised as an expense in the Statement of Financial Activities and a liability on the Balance Sheet immediately at the point the charity is demonstrably committed to either: terminate the employment of an employee or group of employees before normal retirement date; or provide termination benefits as a result of an offer made in order to encourage voluntary redundancy. The charity is considered to be demonstrably committed only when it has a detailed formal plan for the termination and is without realistic possibility of withdrawal from the plan.
## **m) Financial instruments**
The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ of FRS 102 to all of its financial instruments. Financial instruments are recognised in the charity’s balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
assets and liabilities that are not readily apparent from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affected current and future periods.
In the view of the trustees, no assumptions concerning the future or estimation uncertainty affecting assets or liabilities at the balance sheet date are likely to result in a material adjustment to their carrying amounts in the next financial year.
The items in the financial statements where these judgements and estimates have been made include:
- the useful economic lives attributed to tangible fixed assets used to determine the annual depreciation charge;
- the basis of the allocation of staff and support costs across activities; and
- the estimate of future income and expenditure flows for the purposes of assessing the going concern status.
With the exceptions of prepayments and deferred income all other debtor and creditor balances are considered to be basic financial instruments under FRS 102. See notes 13 and 15 for the debtor and creditor notes.
## **n) Critical accounting estimates and areas of judgements**
The preparation of financial statements requires the use of certain accounting estimates. It also requires management to exercise its judgement in the process of applying accounting policies. In the application of the accounting policies, trustees are required to make judgements, estimates, and assumptions about the carrying value of
29
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## **2. Interest receivable**
**----- Start of picture text -----**
Unrestricted Restricted Total
Funds Funds 2025
£ £ £
Bank interest receivable 112,697 520,103 632,800
Unrestricted Restricted Total
Funds Funds 2024
£ £ £
Bank interest receivable 64,251 314,489 378,740
**----- End of picture text -----**
## **3. Income from charitable activities**
**----- Start of picture text -----**
Income from contracts Unrestricted Restricted Total
Funds Funds 2025
£ £ £
NHS England & Wales
Management Support Fee 1,999,456 - 1,999,456
NCAPOP Audits - 8,947,925 8,947,925
NCAPOP Subscriptions - 1,980,000 1,980,000
Subscriptions Admin Fees 20,000 - 20,000
All UK Administrations and Crown Dependencies
CORP Programme Income - 3,414,503 3,414,503
NCAPOP (Scottish Contributions) - 197,440 197,440
Programme Management Fees 235,895 - 235,895
NJR Subscriptions Income - 3,545,502 3,545,502
NJR Other Income - 897,555 897,555
Health Foundation Grants - 20,000 20,000
NHS England: Independent Sector scoping work - 45,000 45,000
Data Access Requests 27,000 - 27,000
Total 2,282,351 19,047,925 21,330,276
**----- End of picture text -----**
30
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## **3. Income from charitable activities (continued)**
**----- Start of picture text -----**
Income from contracts Unrestricted Restricted Total
Funds Funds 2024
£ £ £
NHS England & Wales
Management Support Fee 1,999,455 - 1,999,455
NCAPOP Audits - 9,541,966 9,541,966
NCAPOP Subscriptions - 1,989,900 1,989,900
Subscriptions Admin Fees 20,100 - 20,100
All UK Administrations and Crown Dependencies
CORP Programme Income - 2,833,541 2,833,541
NCAPOP (Scottish Contributions) - 195,970 195,970
Programme Management Fees 218,430 - 218,430
NJR Subscriptions Income - 3,311,343 3,311,343
NJR Other Income - 877,336 877,336
Health Foundation Grants - 20,000 20,000
NHS England: Listening to marginalised voices in maternity - 72,000 72,000
HDR UK Grants - 10,668 10,668
Data Access Requests 32,500 - 32,500
Other New Business 6,600 - 6,600
Total 2,277,085 18,852,724 21,129,809
**----- End of picture text -----**
## **4. Other income**
**----- Start of picture text -----**
Unrestricted Restricted Total
Funds Funds 2025
£ £ £
Miscellaneous income 12,979 - 12,979
Unrestricted Restricted Total
Funds Funds 2024
£ £ £
Miscellaneous income 62,960 - 62,960
**----- End of picture text -----**
31
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## **5. Charitable activities**
**----- Start of picture text -----**
Unrestricted Restricted Total
Funds Funds 2025
£ £ £
Management, development and promotion of clinical audit
National Clinical Audit & Patient Outcomes Programme
(NCAPOP)
NCAPOP Audits - 9,767,937 9,767,937
Clinical Outcome Review Programmes
Programme Costs - 3,760,213 3,760,213
Staff Costs 780,035 427,298 1,207,333
Other Direct Costs - 1,628 1,628
Support Costs 1,158,543 - 1,158,543
1,938,578 13,957,076 15,895,654
National Joint Registry (NJR)
NJR Programme Costs - 2,802,249 2,802,249
Staff Costs - 942,405 942,405
Support Costs - 204,307 204,307
- 3,948,961 3,948,961
NCAB
National Clinical Audit Benchmarking 11,966 - 11,966
11,966 - 11,966
Quality Improvement and Development
Support to local audit - 22,985 22,985
- 22,985 22,985
New Business Activities
Direct Costs - 1,280 1,280
Staff Costs - 152,013 152,013
- 153,293 153,293
1,950,544 18,082,315 20,032,859
**----- End of picture text -----**
32
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## **5. Charitable activities (continued)**
**----- Start of picture text -----**
Unrestricted Restricted Total
Funds Funds 2024
£ £ £
Management, development and promotion of clinical audit
National Clinical Audit & Patient Outcomes Programme
(NCAPOP)
NCAPOP Audits - 9,450,275 9,450,275
Clinical Outcome Review Programmes
Programme Costs - 3,381,983 3,381,983
Staff Costs 714,890 437,335 1,152,225
Other Direct Costs - 1,384 1,384
Support Costs 1,056,601 - 1,056,601
1,771,491 13,270,977 15,042,468
National Joint Registry (NJR)
NJR Programme Costs - 2,788,982 2,788,982
Staff Costs - 840,592 840,592
Support Costs - 187,613 187,613
- 3,817,187 3,817,187
NCAB
National Clinical Audit Benchmarking 6,870 - 6,870
6,870 - 6,870
Quality Improvement and Development
Support to local audit - 21,796 21,796
- 21,796 21,796
New Business Activities
Direct Costs - 6,578 6,578
Staff Costs - 185,032 185,032
- 191,610 191,610
1,778,361 17,301,570 19,079,931
**----- End of picture text -----**
33
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## **6. Support costs**
**----- Start of picture text -----**
Basis of Contract National Joint Stability Total Total
allocation Mgt & Registry Fund 2025 2024
Commissioning Per MOU
£ £ £ £ £
Staff costs (Core Team Staff time 898,383 125,358 - 1,023,741 888,377
Apportioned)
Staff training, recruitment, Headcount/ 30,585 7,987 - 38,572 39,608
HR, life assurance and Activity
other sundry staff costs
Pension Advisory Services Headcount 5,068 1,996 - 7,064 5,723
Financing & Bank Charges Headcount 881 464 - 1,345 1,707
IT support, consultancy, Headcount/ 65,717 34,336 - 100,053 90,313
software and other Work Activity
From Home costs
Communications, website Activity 22,193 - - 22,193 23,891
and marketing costs
Printing, Postage, Activity 6,655 1,596 - 8,251 8,779
Stationery & Supplies
Telephone Headcount 3,299 1,752 - 5,051 7,309
Travel, Subsistence & Activity 14,245 - - 14,245 9,525
Accommodation
Patient & Carer Activity 4,310 - - 4,310 1,070
Engagement Costs
Meeting and facilitation costs Activity 10,710 - - 10,710 14,071
New Business Costs Activity 15,376 - - 15,376 4,995
Insurance Headcount 33,820 15,308 - 49,128 47,959
Professional Fees - Data Headcount 12,131 10,326 - 22,457 47,335
Protection Officer
Depreciation Activity 11,746 779 - 12,525 11,259
Loss on Disposals Activity 4 - - 4 -
Governance:
Audit Fees Income 15,995 4,405 - 20,400 19,500
Corporation Tax Activity (300) - - (300) 1,000
Return Fees
Legal and other Activity 7,725 - - 7,725 21,793
Governance Costs
Trustee expenses Activity - - - - -
1,158,543 204,307 - 1,362,850 1,244,214
**----- End of picture text -----**
34
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## **6. Support costs (continued)**
Support costs have been allocated as follows:
**----- Start of picture text -----**
2025 2024
£ £
Commissioning and contract management of clinical audit 1,158,543 1,056,601
National Joint Registry 204,307 187,613
Stability Fund - -
1,362,850 1,244,214
**----- End of picture text -----**
## **7. Net movement in funds**
This is stated after charging:
||**Unrestricted**|**Restricted**|**Total**
**2025**|
|---|---|---|---|
||£|£|**£**|
|**Auditor's remuneration**||||
|Statutory audit services|15,995|4,405|**20,400**|
|Depreciation|11,746|779|**12,525**|
|||||
||**Unrestricted**|**Restricted**|**Total**
**2024**|
||£|£|£|
|**Auditor's remuneration**||||
|Statutory audit services|16,069|3,431|19,500|
|Depreciation|11,259|-|11,259|
35
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## **8. Employee and staff costs**
**----- Start of picture text -----**
2025 2024
£ £
Wages and Salaries 2,689,808 2,449,059
Social Security Costs 294,888 282,799
Pension Costs 151,775 135,494
Pension Advisory Services 7,064 5,723
Cost of Secondments 139,092 150,559
Cost of Agency Staff 49,929 48,315
3,332,556 3,071,949
**----- End of picture text -----**
Staff costs have been allocated as follows:
**----- Start of picture text -----**
2025 2024
£ £
Management, development and promotion of clinical audit 1,207,333 1,152,225
National Joint Registry 942,405 840,592
New Business Activities 152,013 185,032
Support Costs 1,030,805 894,100
3,332,556 3,071,949
**----- End of picture text -----**
The average number of employees during the period and the actual numbers at 31 March 2025 analysed by function, was as follows:
**----- Start of picture text -----**
2025 2025 2025 2024 2024 2024
Av No. Av No. Actual Av No. Av No. Actual
Total Full time Full time Total Full time Full time
equivalent equivalent equivalent equivalent
Charitable activities
Contract Management 14.9 13.8 12.9 14.9 13.7 14.1
& Commissioning
NJR Team 14.9 12.5 14.1 13.0 10.9 9.9
Management and 15.4 13.5 14.0 14.4 13.3 13.4
Core Services
TOTAL 45.2 39.8 41.0 42.3 37.9 37.4
**----- End of picture text -----**
36
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## **8. Employee and staff costs (continued)**
The number of employees who earned £60,000 per annum or more during the period was
||**2025**|**2024**|
|---|---|---|
|£60,000-70,000|**4**|3|
|£70,000-80,000|**7**|7|
|£80,000-90,000|**4**|5|
|£90,000-100,000|**1**|-|
|£100,000-110,000|**3**|2|
|£150,000-160,000|**1**|-|
Defined pension contributions in respect of the above higher-paid employees totalled £98,236 (2024: £78,071).
Key management personnel include the Trustees, Chief Executive and senior staff reporting directly to the Chief Executive. The total employee benefits of the charity’s key management personnel were **£542,036** (2024: £489,074).
Included in staff costs is £38,781 (2024: £13,005) of termination payments.
## **9. Trustees’ remuneration**
None of the trustees received any remuneration in respect of their services during the period (2024: £Nil).
During the year out of pocket travelling expenses amounting to **£Nil** were reimbursed to no trustees (2024: £Nil
to no trustees).
The charity has purchased insurance to protect the charity from any loss arising from the neglect or defaults of its trustees, employees and agents and to indemnify the trustees or other officers against the consequences of any neglect or default on their part. The insurance premium paid by the charity during the period totalled **£49,128** and provides cover up to a maximum of **£10,000,000** (any one claim or the aggregate during one period of insurance - being 12 months).
## **10. Taxation**
HQIP is a registered charity and therefore is not liable for income tax or corporation tax on income derived from its charitable activities, as it falls within the various exemptions available to registered charities.
37
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## **11. Intangible fixed assets**
||**Website**
**development**
**costs**|
|---|---|
|**Cost**||
|At 1 April 2024 and 31 March 2025|61,089|
|**Amortisation**||
|At 1 April 2024 and 31 March 2025|61,089|
|**Net Book Values**||
|**At 31 March 2025**|-|
|At 31 March 2024|-|
## **12. Tangible fixed assets**
||**Fixtures, fttings &**
**equipment**|
|---|---|
|**Cost**||
|At 1 April 2024|42,597|
|Additions|9,250|
|Disposals|(7,653)|
|At 31 March 2025|44,194|
|**Depreciation**||
|At 1 April 2024|21,864|
|On Disposals|(7,211)|
|Charge for the Year|12,525|
|At 31 March 2025|27,178|
|**Net Book Values**||
|**At 31 March 2025**|17,016|
|At 31 March 2024|20,733|
38
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## **13. Debtors**
**----- Start of picture text -----**
2025 2024
£ £
Trade Debtors 56,539 106,008
VAT Refundable 220,959 243,139
Prepayments & Other Debtors 76,201 56,661
Accrued income 124,659 476,583
478,358 882,391
14. Current asset investments
2025 2024
£ £
Cash equivalents on deposit 5,023,564 4,655,267
**----- End of picture text -----**
## **15. Creditors: Amounts falling due within one year**
**----- Start of picture text -----**
2025 2024
£ £
Trade Creditors 2,701,584 3,255,027
Other Creditors 36,402 29,779
Tax and social security 78,699 75,067
Accruals 1,974,996 1,421,951
Deferred income 184,019 234,935
4,975,700 5,016,759
**----- End of picture text -----**
## **Deferred income**
**----- Start of picture text -----**
2025 2024
£ £
Deferred income at 1 April 2024 234,935 148,000
Amounts released from previous year (138,935) (147,500)
Income deferred in the year 88,019 234,435
Deferred income at 31 March 2025 184,019 234,935
**----- End of picture text -----**
Deferred income relates to income received relating to a future accounting period.
39
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## **16. Restricted funds**
**----- Start of picture text -----**
At 1 April Income Expenditure Transfers At 31 March
2024 2025
£ £ £ £ £
NCAPOP Audits 8,848,272 9,246,602 (9,850,605) 1,372,012 9,616,281
NCAPOP Subscriptions - 1,980,000 (428,926) (1,551,074) -
NCAPOP Scottish Extensions - 197,440 - (197,440) -
NCAPOP Transition Costs 139,822 - - - 139,822
CORP Programme Costs - 3,414,503 (3,760,213) 345,710 -
National Joint Registry 6,596,241 4,664,483 (3,948,961) - 7,311,763
Health Foundation ICS-wide improvement - 20,000 (20,000) - -
enabled by clinical audit
NHS England: Independent Sector scoping work - 45,000 (50,625) 5,625 -
- - -
Support to local audit (22,985) 22,985
15,584,335 19,568,028 (18,082,315) (2,182) 17,067,866
**----- End of picture text -----**
Significant transfers between funds relate to i) subscriptions collected which support the costs of the NCAPOP programme (including CORP programme costs), ii) contributions from Scotland relating to the NCAPOP programme, iii) NCAPOP support to N-QI-CAN.
**----- Start of picture text -----**
At 1 April Income Expenditure Transfers At 31 March
2023 2024
£ £ £ £ £
NCAPOP Audits 7,524,274 9,720,477 (9,533,730) 1,137,251 8,848,272
NCAPOP Subscriptions - 1,989,900 (438,719) (1,551,181) -
NCAPOP Scottish Extensions - 195,970 - (195,970) -
NCAPOP Transition Costs 139,822 - - - 139,822
CORP Programme Costs including PMRT - 2,833,541 (3,381,983) 548,442 -
National Joint Registry 6,088,771 4,324,657 (3,817,187) - 6,596,241
Health Foundation ICS-wide improvement enabled by clinical audit - 20,000 (20,000) - -
NHS England: Listening to marginalised voices - 72,000 (77,487) 5,487 -
in maternity
HDR UK Public involvement in DARG - 10,668 (10,668) - -
- - -
Support to local audit (21,796) 21,796
13,752,867 19,167,213 (17,301,570) (34,175) 15,584,335
**----- End of picture text -----**
40
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## **16. Restricted funds (continued)**
## **NCAPOP - National Clinical Audit and Patient Outcomes Programme**
Management of the National Clinical Audit and Patient Outcomes Programme (NCAPOP), servicing existing contracts and commissioning new audits according to priorities agreed by NHS England.
## **NJR - National Joint Registry**
To fund work to ensure that patients obtain the best clinical care during and following their joint replacement operation. To provide patients, clinicians, healthcare purchasers, commissioners, regulators and implant suppliers with evidence as to which are the best performing implants, ensuring that NHS and other healthcare resources are best used.
## **CORP - Clinical Outcome Review Programmes**
Confidential enquiries designed to stimulate improvements in safety and effectiveness by enabling clinicians, managers and policy makers to learn from adverse events and other relevant data. Coverage is UK-wide, and the programme includes the following topics: deaths following medical and surgical intervention; suicides and homicide among people with mental illness; a child health review; and, maternal, infant and perinatal mortality. One further programme has been commissioned – a national child mortality database.
## **NHS England: Listening to marginalised voices in maternity**
Funding for a project which aimed to identify groups of maternity service users whose voices might be considered ‘less heard’, might experience disadvantage or may have specific needs. The resulting report will feed into a research project to develop a national Patient-Reported Experience Measure (PREM).
## **HDR UK Public involvement in DARG**
Grant to develop meaningful public involvement in HQIP’s data access processes and Data Access Request Group (DARG).
## **Support to local audit**
To fund costs of the National Quality Improvement (Incl. Clinical Audit) Network (N-QI-CAN), a professional network of colleagues undertaking clinical audit and other improvement work across England.
## **NHS England: Independent Sector scoping work**
Funding for a project to scope the requirements of including NHS patients in Independent Sector providers in national clinical audits in England.
## **Health Foundation ICS-wide improvement enabled by clinical audit**
Grant for a project which, supporting improvement in access/flow, inequalities and clinical outcomes, will develop a replicable best-practice method for National Clinical Audit-informed, collaborative Quality Improvement activity across an ICS footprint.
41
TRUSTEES’ REPORT AND ACCOUNTS **2024-25**
## **17. Fixed assets fund**
**----- Start of picture text -----**
At 1 April Additions Depreciation/ Disposals At 31 March
2024 Amortisation 2025
£ £ £ £ £
Fixtures, fittings, 20,733 9,250 (12,525) (442) 17,016
equipment
20,733 9,250 (12,525) (442) 17,016
At 1 April Additions Depreciation/ Disposals At 31 March
2023 Amortisation 2024
£ £ £ £ £
Fixtures, fittings, 19,126 12,866 (11,259) - 20,733
equipment
19,126 12,866 (11,259) - 20,733
**----- End of picture text -----**
The fixed assets fund represents the net book value of the charity’s fixed assets.
## **18. Designated funds**
The income fund of the charity includes the following designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes:
**----- Start of picture text -----**
At 1 April New Utilised/ At 31 March
2024 designations released 2025
£ £ £ £
Stability Fund 446,439 - - 446,439
446,439 - - 446,439
At 1 April New Utilised/ At 31 March
2023 designations released 2024
£ £ £ £
Stability Fund 446,439 - - 446,439
446,439 - - 446,439
**----- End of picture text -----**
The trustees designated a Stability Fund in 2018. The Stability fund is expected to be used to support business development activities, additional IT infrastructure costs and continuity of workstreams over the next 5 years.
42
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
## **19. Analysis of net assets between funds**
**----- Start of picture text -----**
General Fixed Designated Restricted Total
Fund assets Fund Funds Funds 2025
£ £ £ £ £
Fund balances at 31 March 2025
are represented by:
Tangible fixed assets - 17,016 - - 17,016
Current assets 3,588,297 - 446,439 21,778,067 25,812,803
Current liabilities (265,499) - - (4,710,201) (4,975,700)
Total Net Assets 3,322,798 17,016 446,439 17,067,866 20,854,119
General Fixed Designated Restricted Total
Fund assets Fund Funds Funds 2024
£ £ £ £ £
Fund balances at 31 March 2024
are represented by:
Tangible fixed assets - 20,733 - - 20,733
Current assets 3,104,814 - 446,439 20,355,696 23,906,949
Current liabilities (245,398) - - (4,771,361) (5,016,759)
Total Net Assets 2,859,416 20,733 446,439 15,584,335 18,910,923
**----- End of picture text -----**
## **20. Contractual commitments**
## **22. Pension commitments**
At 31 March 2025 the charity had no commitments in respect of contract payments approved for national clinical audits and which had not been accrued due to necessary milestones not being achieved by providers at the year end.
## **21. Contingent liabilities**
During the year ended 31 March 2022, the charity conducted a VAT health check to ensure continuing compliance with latest VAT regulations. The health check identified an underpayment of output VAT which necessitated further investigation and liaison with the relevant funders. No provision was made in previous years due to the fact that the work was ongoing and the value of any liability could not be reliably quantified. This work was concluded during the year ended 31 March 2024 with all remaining amounts recovered from funders and paid over to HMRC.
HQIP operates a money purchase pension scheme which is open to all employees.
Total pension costs in the period were £151,775 (2024: £135,494) and £24,177 (2024: £18,559) were payable at 31 March 2025.
## **23. Related party transactions**
There were no reportable related party transactions in 2025 or 2024.
## **24. Liability of members**
The charity is constituted as a company limited by guarantee. In the event of the charity being wound up members are required to contribute an amount not exceeding £10.
43
128 City Road, London EC1V 2NX
~~